TIMP metallopeptidase inhibitor 1 (TIMP1)

TIMP metallopeptidase inhibitor 1 is a secreted glycoprotein belonging to the tissue inhibitors of metalloproteinases family. It forms one-to-one complexes with target matrix metalloproteinases such as collagenases, irreversibly inhibiting their proteolytic activities essential for normal development, wound healing, pregnancy implantation processes, and tissue remodeling. Beyond its canonical role as an MMP inhibitor regulating extracellular matrix turnover, it also promotes cell proliferation across diverse tissues and exhibits anti-apoptotic effects through both MMP-dependent and independent pathways—including modulation via surface receptors like CD63 that influence intracellular signaling cascades such as Wnt/β-catenin. Dysregulation contributes to pathologies including cancer progression/metastasis, chronic inflammation, cardiovascular disease through myocardial fibrosis induction independent from classical ECM degradation control mechanisms; thus it represents a complex but promising therapeutic target for multiple indications where aberrant ECM dynamics play a central role.[1][2][3][4][5]

Other names

Tissue inhibitor of metalloproteinase 1Metalloproteinase inhibitor 1TIMP-1TPA-inducible protein (less common)

Drugs or biologics targeting this molecule would act by modulating its inhibitory effect on MMPs—either enhancing or blocking its activity to alter extracellular matrix turnover. Potential mechanisms include direct inhibition/activation or disruption/enhancement of interactions with binding partners such as CD63 or integrins for non-MMP-related functions[3][5].